Boston Scientific Corporation v. Micro-Tech Endoscopy USA Inc.

CourtDistrict Court, D. Delaware
DecidedJanuary 15, 2020
Docket1:18-cv-01869
StatusUnknown

This text of Boston Scientific Corporation v. Micro-Tech Endoscopy USA Inc. (Boston Scientific Corporation v. Micro-Tech Endoscopy USA Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Boston Scientific Corporation v. Micro-Tech Endoscopy USA Inc., (D. Del. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE BOSTON SCIENTIFIC CORPORATION _ ) and BOSTON SCIENTIFIC SCIMED, ) INC., ) ) Plaintiffs, ) ) V. ) Civil Action No. 18-1869-CFC-CJB ) MICRO-TECH ENDOSCOPY USA INC., ) MICRO-TECH (NANJING) CO., LTD. ) and HENRY SCHEIN INC., ) ) Defendants. ) REPORT AND RECOMMENDATION In this patent infringement action filed by Plaintiffs Boston Scientific Corp. and Boston Scientific Scimed, Inc. (“Plaintiffs”) against Defendants Micro-Tech (Nanjing) Co., Ltd. (“Micro-Tech Nanjing”) Micro-Tech Endoscopy USA Ine. (“Micro-Tech USA”), and Henry Schein Inc. (“Henry Schein’) (collectively, “Defendants’”), pending is a motion in which: (1) Micro-Tech Nanjing moves for dismissal due to lack of personal jurisdiction, pursuant to Federal Rule of Civil Procedure 12(b)(2); and (2) Defendants each move for dismissal of the operative complaint due to failure to state a claim, pursuant to Federal Rule of Civil Procedure 12(b)(6) (the “Motion”). (D.I. 9) For the reasons set forth below, the Court recommends that the Motion be DENIED. I. BACKGROUND A. Factual Background Plaintiffs develop and manufacture medical devices, including endoscopic products for the treatment of diseases of the digestive system. (D.I. 1 at □□ 2-3) Among the medical devices

that Plaintiffs have developed and sold are the Resolution™ and Resolution 360™ hemostatic clips, which are used to stop bleeding in the gastrointestinal tract. (Id. at J 13) Defendants are also in the business of producing and selling hemostatic clips, and compete with Plaintiffs by selling the allegedly infringing SureClip™, Sure Clip™ MINI and SureClip™ PLUS Hemostasis Clips (the “SureClip Hemostasis Clip products” or the “accused products”). (Id. at] 17) The three Defendants include one foreign and two domestic companies. The foreign company Defendant—Micro-Tech Nanjing—is a corporation organized under the laws of Jiangsu Province, China; it also has its principal place of business located there. (Id. at 95) Micro-Tech Nanjing allegedly manufactures, imports and distributes medical devices, including endoscopic instruments. (/d. at {4 5, 11, 17) Plaintiffs’ Complaint asserts that Micro-Tech Nanjing manufactures the accused products so that they may later be sold in the United States. Cd. at ¥ 11) With regard to Micro-Tech Nanjing’s business, Defendants put forward the sworn declaration of Jie Yin (the “Yin Declaration”), who is described as a “General Manager Assistant” of that company. (D.I. 11 at § 1) The Yin Declaration does not rebut the Complaint’s allegation that Micro-Tech Nanjing manufactures the accused products. And it confirms that Micro-Tech Nanjing “sell[s] certain of these products to Micro-Tech USA,” though it explains that Micro-Tech Nanjing does so “in the country of manufacture or in international waters, not in the United States [such that] Micro-Tech USA takes title to the products outside the United States.” (Id. at §11) The Yin Declaration thus asserts that Micro-Tech Nanjing “does not import those products into the United States, either now or in the past.” (/d.) The Yin Declaration also states that Micro-Tech Nanjing has no direct connection to Delaware. That is,

the Yin Declaration explains that Micro-Tech Nanjing has no real or personal property in Delaware, no officers or employees in Delaware, does not regularly solicit business in or derive

revenue from activities in Delaware, and does not sell any of its products in Delaware. (Jd. at {J 3-4, 6-7) Further, according to the Yin Declaration, it is not possible for Delaware residents to place orders for the accused products through Micro-Tech Nanjing’s website. (/d. at { 9). The two domestic Defendants—Micro-Tech USA and Henry Schein—are Delaware corporations with principal places of business respectively located in Ann Arbor, Michigan and Melville, New York. (D.I. 1 at §/4, 6) Micro-Tech USA and Henry Schein distribute Micro- Tech Nanjing’s devices in the United States. (/d. at {4 4, 6, 17, exs. D-E) Additional information regarding Micro-Tech Nanjing, its relationship with the other two Defendants and the personal jurisdiction issues discussed herein will be set out in Section III.A. B. Procedural Background Plaintiffs filed their Complaint on November 26, 2018. (D.I. 1) While Micro-Tech USA and Henry Schein accepted service of process, (D.I. 5; D.I. 6), Micro-Tech Nanjing filed a waiver of service on December 14, 2018. (D.I. 7) In their Complaint, Plaintiffs assert that Defendants infringe three patents: United States Patent Nos. 9,980,725 (“the '725 patent”), 7,094,245 (“the '245 patent”) and 8,974,371 (“the '371 patent”) (collectively, “the patents-in-suit”). (D.L 1 at { 1) The '725 and '371 patents cover an apparatus for applying hemostatic clips to tissue. (Id. at {{] 23-29, 52-58) The '245 patent covers

an apparatus for causing the hemostasis of a blood vessel for use through an endoscope, (id. at □□ 37-44), as well as a method for using such an apparatus, ('245 patent, cols. 17:26-18:26).!

| The patents-in-suit are attached as exhibits to the Complaint. (D.I. 1, exs. A-C)

Plaintiffs allege that Defendants infringe all three patents by making, using, selling, offering to sell and/or importing into the United States for sale the accused products. (DI. 1 at 17, 22, 35, 51) Additionally, Plaintiffs allege that Defendants induce customers and end-users of the accused products to infringe the method of the '245 patent. (/d. at { 36) Defendants filed the instant Motion on March 13, 2019. (D.I. 9) The Motion was fully briefed by April 3, 2019. (D.I. 20) On July 30, 2019, this case was referred to the Court to hear and resolve all pretrial matters up to and including expert discovery matters. (D.I. 22) Thereafter, the Court held a Case Management Conference and issued a Scheduling Order. (Docket Entry, Sept. 9, 2019; D.I. 29; D.I. 30 (hereinafter “Tr.”)) Before the Court could issue a decision on the instant Motion, however, on September 23, 2019, Plaintiffs filed a motion seeking leave to file a supplemental brief relating to the Motion (the “motion for leave”). With the motion for leave, Plaintiffs sought leave to address their view as to how Federal Rule of Civil Procedure 4(k)(2) applies to the Motion, based in significant part on assertions made by Defendants’ counsel during the Case Management Conference. (D.I. 32) After considering Defendants’ opposition to the motion for leave, (D.I. 33; D.I. 34), the Court granted the motion, accepted Plaintiffs’ opening supplemental brief, and set a schedule for the parties to file supplemental answering and reply briefs, (D.I. 38).” This supplemental briefing was completed on October 18, 2019. (D.I. 43)

2 Defendants challenged Plaintiffs’ attempt to make an argument pursuant to Rule 4(k)(2), arguing that Plaintiffs “belatedly [sought] . . . to present a new argument that could have (and should have . . .) been presented when it opposed the Motion in March [2019].” (D.I. 34 at 1) The Court, however, denied Defendants’ challenge and allowed supplemental briefing, (D.I. 38), noting in part that the United States Court Appeals for the Federal Circuit has stated that

II. STANDARD OF REVIEW A. Personal Jurisdiction, Rule 12(b)(2) and Rule 4(k)(2) Rule 12(b)(2) requires the Court to dismiss any case in which it lacks personal jurisdiction. Fed. R. Civ. P. 12(b)(2); Nespresso USA, Inc. v. Ethical Coffee Co.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Helicopteros Nacionales De Colombia, S. A. v. Hall
466 U.S. 408 (Supreme Court, 1984)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Synthes v. G.M. Dos Reis Jr. Ind. Com. De Equip. Medico
563 F.3d 1285 (Federal Circuit, 2009)
Avocent Huntsville Corp. v. Aten Intern. Co., Ltd.
552 F.3d 1324 (Federal Circuit, 2008)
Litecubes, LLC v. Northern Light Products, Inc.
523 F.3d 1353 (Federal Circuit, 2008)
Goodyear Dunlop Tires Operations, S. A. v. Brown
131 S. Ct. 2846 (Supreme Court, 2011)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Fowler v. UPMC SHADYSIDE
578 F.3d 203 (Third Circuit, 2009)
Power Integrations, Inc. v. BCD Semiconductor Corp.
547 F. Supp. 2d 365 (D. Delaware, 2008)
Daimler AG v. Bauman
134 S. Ct. 746 (Supreme Court, 2014)
Disc Disease Solutions Inc. v. Vgh Solutions, Inc.
888 F.3d 1256 (Federal Circuit, 2018)
M-I Drilling Fluids Uk Ltd. v. Dynamic Air Ltda.
890 F.3d 995 (Federal Circuit, 2018)
Nespresso USA, Inc. v. Ethical Coffee Co. SA
263 F. Supp. 3d 498 (D. Delaware, 2017)
Sincavage v. Barnhart
171 F. App'x 924 (Third Circuit, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
Boston Scientific Corporation v. Micro-Tech Endoscopy USA Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/boston-scientific-corporation-v-micro-tech-endoscopy-usa-inc-ded-2020.